The HPS Network has partnered with the lab of Dr. William Gahl at the National Institutes of Health Genetic Research Institute to create a post/doc position devoted to gene therapy research of HPS. The donation to cover the salary for two years has been given by the HPS Network as well as an additional $20,000/year for supplies. This position has not been filled as of this publication.
Gene therapy holds a lot of promise to treat HPS, but there is still much to learn about the best practices and techniques that would be required. Working with Dr. Gahl is an extraordinary opportunity and this position holds a great deal of promise.
Dr. Gahl’s lab is located at the National Institutes of Health in Bethesda, MD. Until very recently, he was the primary investigator for HPS. His lab discovered three of the known genes that cause HPS and has conducted a number of treatment-oriented clinical trials in hopes of finding a better treatment, or ideally the cure, for HPS.